Back to Search
Start Over
Elevated preoperative neutrophil-lymphocyte ratio predicts upgrading at radical prostatectomy
- Source :
- Prostate cancer and prostatic diseases. 21(1)
- Publication Year :
- 2017
-
Abstract
- Background: Neutrophilâlymphocyte ratio (NLR) is a widely used, representative marker of systemic inflammatory response within the body. NLR can be calculated from simple, inexpensive peripheral blood samples. High NLR is a negative prognostic factor in a variety of malignancies including urological tumors. In this study, we aim to assess the prognostic value of preoperative neutrophil- lymphocyte ratio (NLR) in patients treated with radical prostatectomy (RP) for localized prostate cancer (PCa). Materials and methods: Records of 7426 patients were retrospectively analyzed from prospectively collected datasets. A cut-off point of 3 was taken for NLR based on ROC analyses and previous literature. Results: 23% (n = 1707) of patients had an NLR of â¥3. Patients with NLR â¥3 were more likely to harbor unfavorable pathological features such as higher biopsy Gleason score (GS), higher RP GS, higher rates of extra capsular extension, nodal involvement (all p < 0.001) and positive surgical margins (p = 0.002). On multivariable analyses, NLR ⥠3 was associated with higher RP GS (OR 2.32; p < 0.001), seminal vesicle invasion (OR 1.60; p < 0.001) and nodal involvement (OR 1.43; p < 0.001). On multivariable analyses, NLR ⥠3 was significantly associated with GS upgrading at RP (OR 1.39 p < 0.001). During a median follow up of 45 months, NLR ⥠3 was associated with higher risk of BCR (p = 0.001). However, on multivariable Cox regression analysis such association was not shown (HR 0.86; p = 0.4). Conclusion: Preoperative NLR ⥠3 was associated with aggressive PCa, such as upgrading at RP. Even though its effect on clinical-decision making seems to be limited when all clinical and pathological confounders are taken into account, preoperative NLR may still be useful in selected patients to identify aggressive PCa helping patient selection for active surveillance protocols. Conversely, it does not predict BCR when adjusted for the effect of pathological features.
- Subjects :
- Male
Cancer Research
medicine.medical_specialty
Neutrophils
Urology
Lymphocyte
medicine.medical_treatment
Biopsy
030232 urology & nephrology
Gastroenterology
03 medical and health sciences
Prostate cancer
0302 clinical medicine
Median follow-up
Internal medicine
medicine
Biomarkers, Tumor
Humans
Lymphocytes
Pathological
Aged
Prostatectomy
Tumor
medicine.diagnostic_test
Proportional hazards model
business.industry
fungi
Confounding
Prostate
Prostatic Neoplasms
Middle Aged
Neoplasm Grading
Prognosis
medicine.disease
medicine.anatomical_structure
Oncology
030220 oncology & carcinogenesis
Prostate surgery
business
Biomarkers
Subjects
Details
- ISSN :
- 14765608
- Volume :
- 21
- Issue :
- 1
- Database :
- OpenAIRE
- Journal :
- Prostate cancer and prostatic diseases
- Accession number :
- edsair.doi.dedup.....271807d6513eca83d5d39ec8fdfc82a3